• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰的宫颈癌筛查项目。

Cervical cancer screening programme in Finland.

作者信息

Anttila A, Nieminen P

机构信息

Finnish Cancer Registry, Liisankatu 21B, FIN 00170, Helsinki, Finland.

出版信息

Eur J Cancer. 2000 Nov;36(17):2209-14. doi: 10.1016/s0959-8049(00)00311-7.

DOI:10.1016/s0959-8049(00)00311-7
PMID:11072206
Abstract

In Finland, the organised screening programme for the prevention of cervical cancer has been run for over 30 years and has contributed to a 70-80% decrease in the age-adjusted cervical cancer incidence, as well as a reduction in mortality rates. In this article, we describe the operational details of the organised programme - how the target population is defined, how the invitations are done, how smear tests are collected and analysed, how referrals to confirmation and treatment are conducted, and we also provide recent data on the extent and main screening results. The Finnish programme has led to net savings when assessed for its cost-effectiveness. The results encourage the continuation of the screening programme. By introducing modern screening technologies and more systematic quality control activities in the programme, and by expanding the coverage and compliance we expect to further increase the impact of the programme.

摘要

在芬兰,有组织的宫颈癌预防筛查项目已开展了30多年,使年龄标准化宫颈癌发病率降低了70%至80%,死亡率也有所下降。在本文中,我们描述了该有组织项目的操作细节——目标人群如何界定、如何发出邀请、涂片检查如何采集和分析、如何进行确诊及治疗转诊,并且我们还提供了有关筛查范围和主要筛查结果的最新数据。对芬兰项目的成本效益进行评估时发现其带来了净节约。这些结果鼓励继续开展筛查项目。通过在该项目中引入现代筛查技术和更系统的质量控制活动,以及扩大覆盖范围和提高依从性,我们期望进一步增强该项目的影响力。

相似文献

1
Cervical cancer screening programme in Finland.芬兰的宫颈癌筛查项目。
Eur J Cancer. 2000 Nov;36(17):2209-14. doi: 10.1016/s0959-8049(00)00311-7.
2
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.1963年至1995年芬兰有组织筛查对宫颈癌发病率和死亡率的影响:近期宫颈癌发病率上升
Int J Cancer. 1999 Sep 24;83(1):59-65. doi: 10.1002/(sici)1097-0215(19990924)83:1<59::aid-ijc12>3.0.co;2-n.
3
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.芬兰和荷兰的宫颈癌大规模筛查计划及趋势
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
4
Cervical cancer screening in England.英格兰的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2205-8. doi: 10.1016/s0959-8049(00)00310-5.
5
A screening programme for cervical cancer that worked.一项有效的宫颈癌筛查计划。
Cancer Surv. 1988;7(3):403-16.
6
Cervical cancer screening in the Netherlands.荷兰的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2244-6. doi: 10.1016/s0959-8049(00)00317-8.
7
Cervical cancer screening in Greece.
Eur J Cancer. 2000 Nov;36(17):2227-32. doi: 10.1016/s0959-8049(00)00314-2.
8
Cervical cancer screening programme in Finland with an example on implementing alternative screening methods.芬兰的宫颈癌筛查项目及实施替代筛查方法的实例
Coll Antropol. 2007 Apr;31 Suppl 2:17-22.
9
Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland.筛查效果的显著差异并不能反映芬兰宫颈癌筛查项目的有效性。
Eur J Cancer. 2007 Jan;43(1):169-74. doi: 10.1016/j.ejca.2006.08.026. Epub 2006 Oct 16.
10
Cervical cancer screening in Austria.奥地利的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2189-90. doi: 10.1016/s0959-8049(00)00322-1.

引用本文的文献

1
Prevalence and trends of cervical cancer screening among women in Fiji from 2014 to 2018.2014年至2018年斐济女性宫颈癌筛查的患病率及趋势
Heliyon. 2024 Apr 26;10(9):e30220. doi: 10.1016/j.heliyon.2024.e30220. eCollection 2024 May 15.
2
Human papillomavirus self-sampling with mRNA testing benefits routine screening.人乳头瘤病毒 mRNA 检测的自我采样有益于常规筛查。
Int J Cancer. 2022 Dec 1;151(11):1989-1996. doi: 10.1002/ijc.34170. Epub 2022 Jun 28.
3
A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.
中尼宫颈癌防治比较分析及对北欧国家宫颈癌发病率下降的启示
Int Health. 2021 Jul 3;13(4):307-317. doi: 10.1093/inthealth/ihaa062.
4
Epigenetic IVD Tests for Personalized Precision Medicine in Cancer.用于癌症个性化精准医疗的表观遗传体外诊断测试
Front Genet. 2019 Jun 28;10:621. doi: 10.3389/fgene.2019.00621. eCollection 2019.
5
Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.参与宫颈癌筛查的差异:俄罗斯、索马里和库尔德移民与芬兰普通人群的比较。
Int J Equity Health. 2018 May 4;17(1):56. doi: 10.1186/s12939-018-0768-2.
6
Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.九价人乳头瘤病毒疫苗接种后宫颈癌个体残余风险的估计。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1800-1806. doi: 10.1080/21645515.2018.1450125. Epub 2018 May 24.
7
Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.分子检测可能改善用于宫颈癌预防的HPV筛查和基因分型。
Expert Rev Mol Diagn. 2017 Apr;17(4):379-391. doi: 10.1080/14737159.2017.1293525. Epub 2017 Feb 20.
8
The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.在芬兰,为未参加宫颈筛查的人群提供自行采集样本进行人乳头瘤病毒检测的成本。
BMC Womens Health. 2015 Nov 5;15:99. doi: 10.1186/s12905-015-0261-7.
9
Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.机会性检测在系统性宫颈癌筛查项目中的影响:一项全国性登记研究
BMC Public Health. 2015 Jul 21;15:681. doi: 10.1186/s12889-015-2039-0.
10
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.波兰有组织的宫颈癌筛查计划的实施:对欧洲指南依从性的分析。
BMC Cancer. 2015 Apr 14;15:279. doi: 10.1186/s12885-015-1242-9.